Jianxing, Sichuan, China Related Funds
Funds with similar focus
| Fund Name | Location |
| Ares Management | Chicago, Illinois, United States |
| DEFI Gestion | Lausanne, Switzerland, Vaud |
| Fineseed | Japan, Tokyo |
| Fnaim | - |
| Gardiner Group Capital | Canada, Ontario, Toronto |
| Huiruying Investment | China, Guangdong Province, Huizhou |
| Kilowatt Capital LLC | California, San Francisco, United States |
| Mazor Robotics | Caesarea, Hefa, Israel |
| MissionBlue Capital Partners | China, Hong Kong, Hong Kong Island |
| Mybank | China, Shanghai |
| Nordstjernan | Stockholm, Stockholm County, Sweden |
| Shenzhen Ruige Industrial Development | China, Guangdong, Shenzhen |
| Siena Holdings | Plano, Texas, United States |
| Star Capital Partners | England, London, United Kingdom |
| TowerJazz | Israel, Migdal Haemeq, North District |
| Wind River Ventures | Ellensburg, United States, Washington |
| Yeling Chuangye Touzi | Baoshan, China, Shanghai |
| Zhongguo Minzu Zhengquan | Beijing, Beijing, China |
| Zhuhaishi Tiankuo Touzi Hehuoqiye (Youxian Hehuo) | China, Guangdong, Zhuhai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Leyue Health | 27 Dec 2021 | Shanghai, China | |||
Shukun Technology | $30M | 15 Jun 2020 | China, Beijing | ||
| $28M | 06 Dec 2019 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Leyue Health | 27 Dec 2021 | Shanghai, China | |||
Shukun Technology | $30M | 15 Jun 2020 | China, Beijing | ||
| $28M | 06 Dec 2019 | Dongcheng District, Beijing, China |
